Accurate and timely kidney biopsy interpretation is critical to donor organ utilization and transplant outcomes.
In this on-demand webinar, transplant surgeon Dr. Jeffery Campsen presents findings from a published pilot study evaluating the use of Techcyte Fusion™, an AI-assisted digital pathology platform, for frozen-section donor kidney biopsies.
The study demonstrated that AI-assisted review (AAR):
→ Reduced biopsy review time by over 50%
→ Achieved 98.33% concordance with renal pathology assessments
→ Improved interobserver consistency and eliminated systemic bias
The study demonstrated that AI-assisted review (AAR):
→ Reduced biopsy review time by over 50%
→ Achieved 98.33% concordance with renal pathology assessments
→ Improved interobserver consistency and eliminated systemic bias
